Cannara Biotech, Inc. (LOVE.TO)
1.82
-0.02
(-1.09%)
CAD |
TSX |
Apr 24, 16:00
Cannara Biotech EPS Diluted (Quarterly) : 0.0169 for Feb. 28, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Covalon Technologies Ltd. | 0.0045 |
| MediPharm Labs Corp. | -0.0046 |
| Arch Biopartners, Inc. | -0.0236 |
| Biocure Technology, Inc. | -0.0014 |
| Resverlogix Corp. | -0.001 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 1.663M |
| Revenue (Quarterly) | 27.18M |
| Total Expenses (Quarterly) | 25.52M |
| Enterprise Value | 192.11M |
| Gross Profit Margin (Quarterly) | 20.09% |
| Profit Margin (Quarterly) | 6.12% |
| Earnings Yield | 5.37% |